文献速递主动脉疾病

Ovation支架行EVAR的五年结果:ENCORE数据库分析

Five-year results of endovascular abdominal aortic aneurysm repair with the Ovation abdominal stent graft.
PubMed 文献 · J Vasc Surg · 2019-09-09

基于ENCORE数据库1296例患者的前瞻性汇总数据,回顾性分析Ovation平台行EVAR的5年结果。技术成功率99.7%,30天死亡率0.3%,5年I A型内漏免除率95.8%,动脉瘤相关死亡率免除率99.3%,提示中远期耐久性良好。

要点

  • Ovation平台EVAR的5年I A型内漏免除率为95.8%,I/III型内漏免除率为94.0%。
  • 5年全因死亡免除率78.9%,动脉瘤相关死亡免除率99.3%,30天死亡率为0.3%。
  • 5年器械相关再干预免除率92.4%,瘤囊扩张免除率84.9%。

核心结论

  • Ovation平台EVAR展现出良好的中期耐久性,表现为成功的动脉瘤隔绝和5年动脉瘤相关死亡免除率。

研究设计与样本

  • 回顾性分析ENCORE数据库,汇总5项临床试验和欧盟上市后登记的前瞻性数据,共纳入1296例接受Ovation平台EVAR的患者。

主要发现

  • 技术成功率为99.7%,30天死亡率为0.3%,30天主要不良事件率为1.6%,聚合物泄漏率为0.2%。
  • 1年、3年和5年的I A型内漏免除率分别为97.6%、97.1%和95.8%。
  • 1年、3年和5年的I型或III型内漏免除率分别为96.9%、95.7%和94.0%。
  • 1年、3年和5年的器械相关再干预免除率分别为96.2%、94.4%和92.4%;1年、3年和5年的瘤囊扩张免除率分别为97.0%、90.3%和84.9%。
  • 5年全因死亡免除率和动脉瘤相关死亡免除率分别为78.9%和99.3%。

临床怎么用

  • Ovation平台可用于复杂主动脉解剖患者的EVAR,其中远期内漏免除率和再干预免除率良好。

局限性

  • 本研究为回顾性分析汇总数据,缺乏与其他器械的直接比较,且单器械登记和试验样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Endovascular abdominal aortic aneurysm repair (EVAR) has been rigorously compared with open repair for the treatment of abdominal aortic aneurysms in randomized trials and observational studies, but a comparison of individual devices is lacking, and single-device registries and trials are limited by small sample size. Here we report a descriptive analysis of the Effectiveness of Custom Seal with Ovation: Review of the Evidence (ENCORE) database, pooled results of multiple studies evaluating the midterm results of EVAR with the Ovation Abdominal Stent Graft Platform. METHODS: This is a retrospective analysis of the ENCORE database, a cohort of patients undergoing EVAR with the Ovation platform composed of pooled, prospectively collected data from 1296 patients from five clinical trials and the prospectively maintained European Union Post-Market Registry. The primary outcomes were 5-year rates of type IA and type I or III endoleak. Secondary outcomes included were 30-day mortality, 30-day major adverse event, technical success (successful deployment of the aortic body and iliac limbs), as well as 5-year survival, and freedom from aneurysm-related mortality, type II endoleak, device-related intervention, aneurysm rupture, sac expansion, and conversion to open repair. RESULTS: A total of 1296 patients were included in the analysis. The average age was 73 ± 8 years and 81% of patients were male. Fifty percent of patients had complex aortic anatomy, (neck length <10 mm, neck diameter >28 mm, neck angle >60°, reverse neck taper >10%, distal common iliac artery diameter <10 mm, or external iliac artery diameter <6 mm). Technical success was 99.7%. Thirty-day mortality was 0.3%, 30-day rate of major adverse event was 1.6%, and polymer leak rate was 0.2%. Freedom from type IA endoleak at 1, 3, and 5 years was 97.6%, 97.1%, and 95.8%, respectively; type I or III endoleak at 1, 3, and 5 years was 96.9%, 95.7%, and 94.0%, respectively. Freedom from device-related reintervention at 1, 3, and 5 years was 96.2%, 94.4%, and 92.4% and primary freedom from sac expansion was 97.0% at 1 year, 90.3% at 3 years, and 84.9% at 5 years. Freedom from all-cause mortality and aneurysm-related mortality at 5 years were 78.9% and 99.3%, respectively. CONCLUSIONS: This analysis of the ENCORE database demonstrates that EVAR with the Ovation platform has favorable midterm durability evidenced by successful aneurysm exclusion and 5-year freedom from aneurysm-related mortality.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Swerdlow NJ, Lyden SP, Verhagen HJM, et al. Five-year results of endovascular abdominal aortic aneurysm repair with the Ovation abdominal stent graft. J Vasc Surg. 2019. PMID: 31515176. doi:10.1016/j.jvs.2019.06.196

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。